(Q39169695)

English

Cardiometabolic risk factors are associated with high urinary enterolactone concentration, independent of urinary enterodiol concentration and dietary fiber intake in adults

scientific article published on 25 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Cardiometabolic risk factors are associated with high urinary enterolactone concentration, independent of urinary enterodiol concentration and dietary fiber intake in adults (English)

1 reference

Europe PubMed Central

9 September 2017

Cara L Frankenfeld

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966407%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Cara L Frankenfeld

1

1 reference

Europe PubMed Central

9 September 2017

language of work or name

0 references

publication date

25 June 2014

1 reference

Europe PubMed Central

9 September 2017

Journal of Nutrition

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966407%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

144

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966407%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966407%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1445-1453

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966407%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Nutritional quality of legumes, and their role in cardiometabolic risk prevention: a review.

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Dietary fiber intake and cardiometabolic risks among US adults, NHANES 1999-2010.

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Dietary intake and main sources of plant lignans in five European countries

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Dietary lignans: physiology and potential for cardiovascular disease risk reduction

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Relationship of obesity and high urinary enterolignan concentrations in 6806 children and adults: analysis of National Health and Nutrition Examination Survey data.

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Metabolic syndrome as a risk factor for diabetes

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Urinary enterolignan concentrations are positively associated with serum HDL cholesterol and negatively associated with serum triglycerides in U.S. adults

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Human intestinal bacterium, strain END-2 is responsible for demethylation as well as lactonization during plant lignan metabolism

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Identification of lignans and phytoestrogens in urine of chimpanzees.

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Mammalian phytoestrogens: enterodiol and enterolactone

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Enterolactone as a risk factor for breast cancer: a review of the published evidence.

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Meta-analyses of lignans and enterolignans in relation to breast cancer risk

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genes.

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Plasma enterolactone and breast cancer risk in the Nurses' Health Study II

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Plasma enterolignans are not associated with nonfatal myocardial infarction risk

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Validation of FFQ-based assessment of dietary lignans compared with serum enterolactone in Swedish women

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.190512

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39169695&oldid=1811605110"